Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-98-001372
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
6
Period of Report
1997-12-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 136404
2 COOPERATIVE RESEARCH AND DEVELOPMENT WITH THE FDA EX-10.12 20328
3 LICENSE AGREEMENT WITH NATL INSTITUTE OF HEALTH EX-10.13 61542
4 EMPLOYMENT AGREEMENT BETWEEN HUSSEY AND THE CO. EX-10.14 22181
5 CALCULATION OF EARNINGS EX-11.1 1059
6 FINANCIAL DATA SCHEDULE EX-27 2094
  Complete submission text file 0000950137-98-001372.txt   245672
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 225 EAST DEERPATH STE 250 LAKE FOREST IL 60045 7082958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 98582980
SIC: 8731 Services-Commercial Physical & Biological Research